0001595262-16-000063.txt : 20161003
0001595262-16-000063.hdr.sgml : 20161003
20161003185418
ACCESSION NUMBER: 0001595262-16-000063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161003
FILED AS OF DATE: 20161003
DATE AS OF CHANGE: 20161003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMS Health Holdings, Inc.
CENTRAL INDEX KEY: 0001595262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 83 WOOSTER HEIGHTS ROAD
CITY: DANBURY
STATE: CT
ZIP: 06810
BUSINESS PHONE: 203-448-4600
MAIL ADDRESS:
STREET 1: 83 WOOSTER HEIGHTS ROAD
CITY: DANBURY
STATE: CT
ZIP: 06810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bruehlman Ronald E
CENTRAL INDEX KEY: 0001604076
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36381
FILM NUMBER: 161916911
MAIL ADDRESS:
STREET 1: C/O IMS HEALTH HOLDINGS, INC.
STREET 2: 83 WOOSTER HEIGHTS ROAD
CITY: DANBURY
STATE: CT
ZIP: 06810
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-10-03
1
0001595262
IMS Health Holdings, Inc.
IMS
0001604076
Bruehlman Ronald E
C/O IMS HEALTH HOLDINGS, INC.
83 WOOSTER HEIGHTS ROAD
DANBURY
CT
06810
0
1
0
0
See Remarks
Common Stock
2016-10-03
4
A
0
20935
A
112655
D
Common Stock
2016-10-03
4
A
0
35828
A
148483
D
Common Stock
2016-10-03
4
D
0
148483
D
0
D
Employees Stock Option (right to buy)
11.20
2016-10-03
4
D
0
60000
D
2012-07-16
2021-07-16
Common Stock
60000
0
D
Employees Stock Option (right to buy)
7.00
2016-10-03
4
D
0
60000
D
2013-07-16
2021-07-16
Common Stock
60000
0
D
Employees Stock Option (right to buy)
4.40
2016-10-03
4
D
0
230000
D
2016-07-16
2021-07-16
Common Stock
230000
0
D
Stock Appreciation Right
25.02
2016-10-03
4
D
0
11798
D
2016-02-10
2025-02-10
Common Stock
11798
0
D
Stock Appreciation Right
25.02
2016-10-03
4
D
0
35397
D
2025-02-10
Common Stock
35397
0
D
Stock Appreciation Right
23.00
2016-10-03
4
D
0
79745
D
2026-02-02
Common Stock
79745
0
D
On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc.
On February 10, 2015 the reporting person was granted 17,563 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2015 - December 31, 2017). In connection with the merger and based on the performance criteria achieved, 20,935 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 8,039 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2017
On February 2, 2016, the reporting person was granted 26,019 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2016 - December 31, 2018). In connection with the merger and based on the performance criteria achieved, 35,828 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 13,757 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2018.
Disposed of pursuant to merger agreement in exchange for 57,017 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $29.17 per share.
This option was assumed by Quintiles in the merger and replaced with an option to purchase 23,040 shares of Quintiles IMS Holdings, Inc. common stock at a price of $18.23 per share.
This option was assumed by Quintiles in the merger and replaced with an option to purchase 88,320 shares of Quintiles IMS Holdings, Inc. common stock at a price of $11.46 per share.
This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 4,530 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.
This stock appreciation right vests in three annual installments beginning on February 10, 2017.
This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 13,592 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.
This stock appreciation right vests in four annual installments beginning on February 2, 2017.
This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 30,622 shares of Quintiles IMS Holdings, Inc. common stock at a price of $59.90 per share.
Senior VP & Chief Financial Officer
/s/ Harvey A. Ashman, Attorney-in-Fact
2016-10-03